Also known as آسٹیوپوروسس مینجمنٹ
Diabetologist
MD
Cardiologist
MBBS, FCPS (Medicine), FCPS (Cardiology)
Rheumatologist
MBBS, MCPS, MRCGP, DTTMH, MASTMH, MRACGP, Family Medicine Residency Training Certification
Rheumatologist
MBBS, MCPS, MRCGP, DTTMH, MASTMH, MRACGP, Family Medicine Residency Training Certification
Internal Medicine Specialist
MBBS, FCPS (Medicine),
Diabetologist
MBBS, FCPS , FRCP, MRCP, M.Sc (Diabetes)
Diabetologist
MBBS, MPhil, Diploma in Diabetology
Consultant Physician
F.C.P.S, M.C.P.S, M.B.B.S
Endocrinologist
M.B.B.S, Dip. in Diabetology, MACE (USA), FRSPH (UK)
Endocrinologist
M.B.B.S, Dip. in Diabetology, MACE (USA), FRSPH (UK)
Internal Medicine Specialist
MBBS, MCPS, Doctorate Of Medicine (M.D)
Internal Medicine Specialist
M.B.B.S., M.R.C.P. (UK)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures